Sallie Mae 2012 Annual Report Download - page 162

Download and view the complete annual report

Please find page 162 of the 2012 Sallie Mae annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 207

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207

SLM CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. Derivative Financial Instruments (Continued)
Although we use derivatives to offset (or minimize) the risk of interest rate and foreign currency changes,
the use of derivatives does expose us to both market and credit risk. Market risk is the chance of financial loss
resulting from changes in interest rates, foreign exchange rates and market liquidity. Credit risk is the risk that a
counterparty will not perform its obligations under a contract and it is limited to the loss of the fair value gain in
a derivative that the counterparty owes us. When the fair value of a derivative contract is negative, we owe the
counterparty and, therefore, have no credit risk exposure to the counterparty; however, the counterparty has
exposure to us. We minimize the credit risk in derivative instruments by entering into transactions with highly
rated counterparties that are reviewed regularly by our Credit Department. We also maintain a policy of requiring
that all derivative contracts be governed by an International Swaps and Derivative Association Master
Agreement. Depending on the nature of the derivative transaction, bilateral collateral arrangements generally are
required as well. When we have more than one outstanding derivative transaction with the counterparty, and
there exists legally enforceable netting provisions with the counterparty (i.e., a legal right to offset receivable and
payable derivative contracts), the “net” mark-to-market exposure, less collateral the counterparty has posted to
us, represents exposure with the counterparty. When there is a net negative exposure, we consider our exposure
to the counterparty to be zero. At December 31, 2012 and 2011, we had a net positive exposure (derivative gain
positions to us less collateral which has been posted by counterparties to us) related to SLM Corporation and the
Bank derivatives of $79 million and $113 million, respectively.
Our on-balance sheet securitization trusts have $13.0 billion of Euro and British Pound Sterling
denominated bonds outstanding as of December 31, 2012. To convert these non-U.S. dollar denominated bonds
into U.S dollar liabilities, the trusts have entered into foreign-currency swaps with highly–rated counterparties. In
addition, the trusts have entered into $14.2 billion of interest rates swaps which are primarily used to convert
Prime received on securitized student loans to LIBOR paid on the bonds. At December 31, 2012, the net positive
exposure on swaps in securitization trusts is $889 million.
Recent turmoil in the European markets has led to increased disclosure of exposure to those markets. Our
securitization trusts had total net exposure of $764 million related to financial institutions located in France; of
this amount, $555 million carries a guaranty from the French government. The total exposure relates to
$6.4 billion notional amount of cross-currency interest rate swaps held in our securitization trusts, of which
$3.6 billion notional amount carries a guaranty from the French government. Counterparties to the cross currency
interest rate swaps are required to post collateral when their credit rating is withdrawn or downgraded below a
certain level. As of December 31, 2012, no collateral was required to be posted and we are not holding any
collateral related to these contracts. Adjustments are made to our derivative valuations for counterparty credit
risk. The adjustments made at December 31, 2012 related to derivatives with French financial institutions
(including those that carry a guaranty from the French government) decreased the derivative asset value by
$94 million. Credit risks for all derivative counterparties are assessed internally on a continual basis.
Accounting for Derivative Instruments
Derivative instruments that are used as part of our interest rate and foreign currency risk management
strategy include interest rate swaps, basis swaps, cross-currency interest rate swaps, interest rate futures
contracts, and interest rate floor and cap contracts with indices that relate to the pricing of specific balance sheet
assets and liabilities. The accounting for derivative instruments requires that every derivative instrument,
including certain derivative instruments embedded in other contracts, be recorded on the balance sheet as either
an asset or liability measured at its fair value. As more fully described below, if certain criteria are met,
derivative instruments are classified and accounted for by us as either fair value or cash flow hedges. If these
criteria are not met, the derivative financial instruments are accounted for as trading.
F-52